Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Perspective Therapeutics (CATX)
NYSE MKT:CATX
RESEARCH TOOLSreports
Perspective Therapeutics (CATX) Ownership - Who Owns Perspective Therapeutics?
977 Followers
Perspective Therapeutics (CATX) Ownership Overview
21.09% Insiders
2.74% Mutual Funds
26.52% Other Institutional Investors
49.66% Public Companies and Individual Investors
The ownership structure of Perspective Therapeutics (CATX) stock is a mix of institutional, retail and individual investors. Approximately 29.26% of the company’s stock is owned by Institutional Investors, 21.09% is owned by Insiders and 49.66% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
| Apr 24, 2024 | Mark John Austin Vp Finance/prin Fin&acct Offic | Bought | $54000 |
| Mar 08, 2024 | Lantheus Alpha Therapy, Llc >10% Owner | Bought | $57409487 |
| Feb 01, 2024 | Robert F Iii Williamson Director | Bought | $90710 |
| Jan 30, 2024 | Robert F Iii Williamson Director | Bought | $78474 |
Recent Hedge Fund Trading Activity
Date | Firm | Activity | Value |
|---|---|---|---|
| Dec 31, 2023 | Bought | $57305 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 17,103,233 | Institution | 2.91% | 30,101,690 | |
| 12,778,801 | Institution | 2.18% | 22,490,690 | |
| 7,639,703 | Institution | 1.30% | 13,445,877 | |
| 2,461,077 | Institution | 0.42% | 4,331,496 | |
| 535,243 | Institution | 0.09% | 942,028 | |
| 342,550 | Institution | 0.06% | 602,888 | |
| 326,402 | Insider | 0.06% | 574,468 | |
| 316,333 | Insider | 0.05% | 556,746 | |
| 251,620 | Institution | 0.04% | 442,851 | |
| 184,000 | Institution | 0.03% | 323,840 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 12,778,801 | Institution | 2.18% | 22,490,690 | |
| 2,461,077 | Institution | 0.42% | 4,331,496 | |
| 251,620 | Institution | 0.04% | 442,851 | |
| 184,000 | Institution | 0.03% | 323,840 | |
| 140,923 | Institution | 0.02% | 248,024 | |
| 116,009 | Institution | 0.02% | 204,176 | |
| 104,951 | Institution | 0.02% | 184,714 | |
| 15,959 | Institution | <0.01% | 28,088 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 10,340,272 | Institution | 1.76% | 12,304,924 | |
| 6,762,961 | Institution | 1.15% | 8,047,924 | |
| 535,243 | Institution | 0.09% | 942,028 |
FAQ
Who Owns Perspective Therapeutics (CATX)?
According to the latest TipRanks data, approximately 26.52% of the company's stock is held by institutional investors, 21.09% is held by insiders, and 49.66% is held by retail investors.
What percentage of Perspective Therapeutics (CATX) stock is held by institutional investors?
According to the latest TipRanks data, approximately 26.52% of Perspective Therapeutics (CATX) stock is held by institutional investors.
What percentage of Perspective Therapeutics (CATX) stock is held by retail investors?
According to the latest TipRanks data, approximately 49.66% of Perspective Therapeutics (CATX) stock is held by retail investors.
Who owns the most shares of Perspective Therapeutics (CATX)?
Vanguard owns the most shares of Perspective Therapeutics (CATX).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.